How Do Transplant Surgeons Accomplish Optimal Portal Venous Flow During Living-Donor Liver Transplantation? Noninvasive Measurement of Indocyanine Green Elimination Rate

2013 ◽  
Vol 21 (1) ◽  
pp. 43-51 ◽  
Author(s):  
Tomohide Hori ◽  
Yasuhiro Ogura ◽  
Shintaro Yagi ◽  
Taku Iida ◽  
Kentaro Taniguchi ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Indocyanine Green ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Elimination Rate ◽  
Noninvasive Measurement ◽  
Portal Venous Flow ◽  
Donor Liver ◽  
Venous Flow ◽  
Donor Liver Transplantation

Indocyanine Green Dye Excretion in Bile Reflects Graft Function After Living Donor Liver Transplantation

2009 ◽  
Vol 88 (5) ◽  
pp. 747-748 ◽  
Author(s):  
Susumu Eguchi ◽  
Mitsuhisa Takatsuki ◽  
Kosho Yamanouchi ◽  
Masaaki Hidaka ◽  
Akihiko Soyama ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Indocyanine Green ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Graft Function ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Indocyanine Green Dye

Adult-to-Adult Living-Donor Liver Transplantation

Swiss Surgery ◽  
2003 ◽  
Vol 9 (5) ◽  
pp. 227-236 ◽  
Author(s):  
Majno ◽  
Mentha ◽  
Berney ◽  
Bühler ◽  
Giostra ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Therapeutic Option ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Multidisciplinary Program ◽  
First Case ◽  
Living Donor Transplantation ◽  
The Right

Living donor liver transplantation is a relatively new procedure in which the right side of the liver is harvested in a healthy donor and transplanted into a recipient. After the first case in 1994, over 3000 cases have been done worldwide. This review summarizes the reasons why the procedure is needed, describes its main technical aspects, highlights the boundaries in which it can be done safely, summarizes the current experience worldwide and describes the main points of the program in our unit. We argue that living-donor transplantation is a viable alternative to a long time on the waiting list for several patients, and it can be performed safely and successfully provided that all precautions are undertaken to minimize the risks in the donor and to increase the chances of a good outcome in the recipients. If these prerequisites are met, and within the framework of a structured multidisciplinary program, we believe that living-donor liver transplantation should be funded by health insurances as a recognized therapeutic option.

Sign in / Sign up

Export Citation Format

Share Document